SCHEMBL8602934

SCHEMBL8602934

FCCCCCCCCBr

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL985651 1.00
SCHEMBL1009362 1.00 TSHR (0.33) TSHR
SCHEMBL8020724 1.00
SCHEMBL7558589 1.00 TSHR (0.33) TSHR
SCHEMBL11072586 1.00 TSHR (0.33) TSHR
SCHEMBL9142636 1.00 TSHR (0.33) TSHR
SCHEMBL1798324 1.00
SCHEMBL18702356 1.00 TSHR (0.33) TSHR
SCHEMBL20957495 1.00 TSHR (0.33) TSHR
SCHEMBL21060944 1.00 TSHR (0.33) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113491711-A Antibacterial oxygen solution and preparation method and application thereof 广州丰歌生物科技有限责任公司 2021-10-12 CN claimed
CN-108137621-B Novel method for preparing aminosilane compounds 株式会社LG化学 2021-07-06 CN claimed
US-10556918-B2 Method for preparing aminosilane-based compound LG CHEM, LTD. (KR) 2020-02-11 US claimed
EP-3330273-B1 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG CHEMICAL LTD (KR) 2019-06-19 EP claimed
US-20180282353-A1 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG CHEM, LTD. (KR) 2018-10-04 US claimed
EP-3330273-A2 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND LG Chem, Ltd. (KR) 2018-06-06 EP claimed
EP-0647131-A1 DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN. LANCASTER GROUP AG (DE) 1995-04-12 EP claimed
EP-0645997-A1 COSMETIC CONTAINING PHOSPHOLIPIDS AND FLUOROCARBON COMPOUNDS. LANCASTER GROUP AG (DE) 1995-04-05 EP claimed
WO-1994000098-A1 COSMETIC CONTAINING PHOSPHOLIPIDS AND FLUOROCARBON COMPOUNDS LANCASTER GROUP AG (DE) 1994-01-06 WO claimed
WO-1994000109-A1 DERMATOLOGICAL AGENT FOR AIDING OXYGEN TRANSPORT IN THE SKIN LANCASTER GROUP AG (DE) 1994-01-06 WO claimed
CN-111954848-B Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member DIC株式会社 2024-05-03 CN disclosed
CN-116917029-A Microparticles and microparticle dispersions 国立大学法人东京大学 2023-10-20 CN disclosed
CN-114949268-A Fluorine-coated mesoporous polydopamine nanoparticle and synthesis method and application thereof 中国科学院精密测量科学与技术创新研究院 2022-08-30 CN disclosed
CN-109153653-B Novel compound, photocurable composition, cured product thereof, printing ink, and printed matter using the printing ink DIC株式会社 2022-06-28 CN disclosed
CN-113491711-A Antibacterial oxygen solution and preparation method and application thereof 广州丰歌生物科技有限责任公司 2021-10-12 CN disclosed
EP-0663821-A1 FLUOROCARBON BLOOD SUBSTITUTE SEGEL, Leigh D. (US) 1995-07-26 EP disclosed
US-5374624-A Aqueous emulsion with phospholipid emulsifier SEGEL LEIGH D (US) 1994-12-20 US disclosed
WO-1993002653-A1 FLUOROCARBON BLOOD SUBSTITUTE SEGEL LEIGH D (US) 1993-02-18 WO disclosed
US-4455441-A ALPHA-FLUORO-OMEGA HYDROXY STRAIGHT CHAIN HYDROCARBONS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-06-19 US disclosed
EP-0104880-A2 Attractant termiticidal compounds, compositions and methods of use therefor THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282353-A1 NOVEL METHOD FOR PREPARING AMINOSILANE-BASED COMPOUND SRM, MSN, CAD TSHR 4452/4885
US-10556918-B2 Method for preparing aminosilane-based compound SRM, CAD, MSN TSHR 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.